We previously reported that CAPE treatment repressed the cellular survival, proliferation, and tumor growth of both androgen-dependent and CRPC PCa cell lines via inhibition of PI3K-Akt and c-Myc signaling [18–20]. The gene discussed is AKT1; the disease is posterior cortical atrophy.